REFERENCES
- Hillier ER. Oral morphine mixtures. BMJ. 1983;287:701–702.
- Wiffen PJ, McQuay HJ. Oral morphine for cancer pain [review]. Cochrane Database Syst Rev. 2007;(4): CD003868. Available at: http://www.thecochranelibrary.com. Accessed 21 July 2010.
- De Conno F, Ripamonti C, Fafnoni E, The MERITO Study: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during ‘titration phase’ in patients with cancer pain. Palliat Med. 2008;22:214–221.
- Merriman A, Harding R. Pain control in the African context: the Ugandan introduction of affordable morphine to relieve suffering at the end of life. Philos Ethics Humanit Med. 2010;5–10.
- Ripamonti CI, Campa T, Fagnoni E, Brunelli C, Luzzani M, Maltoni M, De Conno F; MERITO Study Group. Normal-release oral morphine starting dose in cancer patients with pain. Clin J Pain. 2009;25:386–390.
- Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Validity of four pain intensity rating scale. Pain. 2011;152:2399–2404.
- Ajayi IO, Soyannwo OA, Adebamowo CA, Amanor-Boadu SD. Availability of opioids for cancer pain in Nigeria. Nig J Surg. 2000;7:25–28.
- Nuessle S, Gray A, Lambert G, Pain control with morphine: evaluation of prescriptions for oral morphine for outpatients at King Faisal Specialist Hospital and Research Centre. Ann Saudi Med. 1996;16:371–376.
- Adebamowo CA, Akarolo-Anthony. Cancer in Africa: opportunities for collaborative research and training. Afr J Med Med Sci. 2009;38(Suppl):5–13.
- Umezulike AC, Tabansi SN, Ewunonu HA, Nwana EJ. Epidemiological characteristics of carcinoma of the cervix in the Federal Capital Territory of Nigeria. Niger J Clin Pract. 2007;10:143–146.
- Bercovitch M, Waller A, Adunsky A. High dose morphine use in the Hospice setting and effect on life expectancy. Cancer. 1999;86:871–877.
- Droney J, Ross J, Gretton S, Welsh K, Sato H, Riley J. Constipation in cancer patients on morphine. Support Care Cancer. 2008;16:453–459.
- Mercadante S, Ferrera P, Casuccio A. Effectiveness and tolerability of Amidotrizoate for the treatment of constipation resistant to laxatives in advanced cancer patients. J Pain Symptom Manage. 2011;41(2):421–425.